Global Peptic Ulcer Drugs Market 2017-2021

This industry research report identifies AstraZeneca, Daewoong Pharmaceuticals, Eisai, and Takeda Pharmaceutical as the key vendors in the global peptic ulcer drugs market. This industry research report also presents a competitive analysis of the market by drug class (Proton pump inhibitors (PPIs) and Antibiotics) and by geography (the Americas, APAC, and EMEA.

Global peptic ulcer drugs market forecast

According to the peptic ulcer drugs industry analysis, the global peptic ulcer drugs market will grow steadily at a CAGR of close to 3% by 2021. This market research analysis identifies the overuse of over-the-counter (OTC) anti-inflammatory drugs which will drive the peptic ulcer drugs market growth. The long-term use of the non-steroidal anti-inflammatory drug (NSAIDs) can cause dysregulation of defense mechanism that aids in the protection of gastric mucosal membrane, thereby leading to the formation of ulcers. Hence, the overuse of anti-inflammatory drugs increases the risk of formation of peptic ulcers, which, in turn, increases the demand for more peptic ulcer medication.

Get A Free Sample 

The rise in the awareness about peptic ulcers in individuals is one of the emerging trends in the global peptic ulcer drugs market in the coming years. The public health programs led by government organizations to raise awareness among people about the disease have been increased.  For instance, the Centres for Disease Control and Prevention (CDC) released a public service announcement to educate the common people about the disease, its causes, and treatment options.

Competitive landscape and key vendors

The peptic ulcer drugs market is a fragmented market with the presence of large players. The players in the market compete based on factors such as the geographical presence, stable supply chain logistics, patent expiry, and new approvals of already established/expired drugs for additional indications. Additionally, it has also been noted that the patent expiry is expected to pose a challenge to the players during the forecast period.

The leading vendors in the market are 

• AstraZeneca
• Daewoong Pharmaceuticals
• Eisai
• Takeda Pharmaceutical

The other prominent vendors in the market include GlaxoSmithKline and Pfizer.

Segmentation by drug class and analysis of the peptic ulcer drugs market

• Proton pump inhibitors (PPIs)
• Antibiotics

 During 2016, the PPIs segment accounted for the major shares of this market. The market is growing due to high efficacy of these drugs to heal ulcers by reducing acid secretion, inflammation, and pain caused because of ulceration. Additionally, the therapeutic benefits of PPIs along with their agonizing effect as a conjunct with antibiotics is likely to increase the demand for these drugs, thereby driving the market growth.

Geographical segmentation and analysis of the peptic ulcer drugs market

• Americas
• APAC
• EMEA

This market study estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the market by 2021. This is due to the rising prevalence of peptic ulcer disease in this region, coupled with the availability of improved diagnostics that help in early detection of symptoms, thereby increasing patient pool seeking treatment.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the market size, market forecast, and the growth rate be in 2021?
• What are the key factors driving the global peptic ulcer drugs market?
• What are the key market trends impacting the growth of the global peptic ulcer drugs market?
• What are the challenges to market growth?
• Who are the key vendors in the global peptic ulcer drugs market?
• What are the market opportunities and threats faced by the vendors in the global peptic ulcer drugs market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global peptic ulcer drugs market?

Technavio also offers customization on reports based on specific client requirement.